FDA Inspection 1243703 — Seock-Ah Im, MD, PhD

Seock-Ah Im, MD, PhD — FEI 3009399572

The FDA completed an inspection of Seock-Ah Im, MD, PhD on Jul 12, 2024 in Seoul. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 12, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Seoul (Korea (the Republic of))

Additional Details

Clinical Investigator (CI)